Wang, B. Letter to the editor: Safety and efficacy of PD-1 inhibitor (sintilimab) combined with transarterial chemoembolization as the initial treatment in patients with intermediate-stage hepatocellular carcinoma beyond up-to-seven criteria. BMJ Publishing Group.
Chicago Style (17th ed.) CitationWang, Bi-Cheng. Letter to the Editor: Safety and Efficacy of PD-1 Inhibitor (sintilimab) Combined with Transarterial Chemoembolization as the Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond Up-to-seven Criteria. BMJ Publishing Group.
MLA (9th ed.) CitationWang, Bi-Cheng. Letter to the Editor: Safety and Efficacy of PD-1 Inhibitor (sintilimab) Combined with Transarterial Chemoembolization as the Initial Treatment in Patients with Intermediate-stage Hepatocellular Carcinoma Beyond Up-to-seven Criteria. BMJ Publishing Group.